News

Biotech Firms Grant New-Hire Stock Options

Business

Biotech Firms Grant New-Hire Stock Options

7 sourcesUpdated Nov 5, 20261 min read

0

Biotech Firms Grant New-Hire Stock Options — © IJR

Sponsored

Milestone Pharmaceuticals, Zentalis Pharmaceuticals, Dianthus Therapeutics and C4 Therapeutics each announced stock-option grants to newly hired employees as employment inducements under Nasdaq rules. The grants ranged from 26,000 options at Dianthus to 136,000 options for four hires at Zentalis; Milestone granted 33,000 options to one hire, and C4 granted 85,480 options to one hire. The awards generally vest over four years, with vesting contingent on continued employment.

Sponsored

In this story:

More on this story

Back to News

Finance

ConocoPhillips Q3 Profit Doubles, Raises Dividend 11%

ConocoPhillips more than doubled Q3 profit to about $4 billion on a 32% jump in realized prices and raised its quarterly dividend 11% to $0.93 a share.

7 sources

Finance

Stocks Slide After Democratic Victories Raise Tech Scrutiny Fears

Wall Street and global markets fell after Democrats’ projected midterm sweep raised expectations of tighter scrutiny of technology and AI companies and uncertainty over President Trump’s agenda; Treasuries gained as investors anticipated possible limits on tax cuts and spending. Trump Media shares also slid, underscoring pressure on assets tied closely to Trump’s political fortunes.

Total sources

7

Last updatedNov 5, 2026

Does this breakdown look right?

Sponsored

How it spread

Broke stocktitan.net · Nov 2, 4:01 PM ETCenter +2d7 sources +3d on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored

5 sources

Sponsored

Finance

U.S. Stocks Erase Morning Gains, Tech Slides

U.S. stocks gave back much of an early rally Monday as technology and AI shares reversed course amid worries about Big Tech’s costly AI investments and signs of pressure on established businesses. Falling oil prices tied to hopes for progress in U.S.-Iran talks supported many stocks, but the Nasdaq ended lower while the Dow rose.

6 sources